Press-release for stocks for LLY

symbols : LLY crawled time : 12:20

save search

Lilly's Retevmo® (selpercatinib) Demonstrates Superior Progression-Free Survival Compared to Approved Multikinase Inhibitors in RET-Mutant Medullary Thyroid Cancer
Published: 2023-08-22 (Crawled : 12:20) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M

Health Technology

| 34.89% | O: 0.3% H: 1.19% C: 0.75%
retevmo approved cancer thyroid

Lilly Completes Acquisition of Sigilon Therapeutics
Published: 2023-08-14 (Crawled : 12:20) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M

Health Technology

| 41.78% | O: 2.56% H: 0.0% C: 0.0%
acquisition therapeutics

Precision BioSciences Reports Second Quarter 2023 Financial Results and Provides Business Update
Published: 2023-08-04 (Crawled : 12:20) - precisionbiosciences.com
NVS | News | $98.35 1.1% 0.0% 2.2M

Health Technology

| -3.12% | O: -0.38% H: 0.73% C: 0.15%
LLY | News | $732.2 -1.81% 0.18% 2.1M

Health Technology

| 63.7% | O: -0.53% H: 0.0% C: 0.0%
DTIL | $9.81 -4.11% -4.28% 34K

Health Technology

| 1727.11% | O: -0.95% H: 0.0% C: 0.0%
business update financial results

Veru to Report Fiscal 2023 Third Quarter Financial Results on August 10, 2023
Published: 2023-08-03 (Crawled : 12:20) - globenewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M

Health Technology

| 61.9% | O: -1.1% H: 0.0% C: 0.0%
VERU | $1.325 3.92% 3.77% 1.5M

Health Technology

| 8.55% | O: -0.85% H: 3.45% C: 0.86%
report financial results

Longeveron Welcomes Three New Prominent Board Members
Published: 2023-06-13 (Crawled : 12:20) - globenewswire.com
LGVN | $1.73 -4.95% -5.2% 300K

| -50.27% | O: 2.46% H: 2.93% C: 0.8%
LLY | News | $732.2 -1.81% 0.18% 2.1M

Health Technology

| 65.96% | O: -0.37% H: 0.84% C: 0.46%
PCSA | $1.67 4.38% 4.19% 40K

Producer Manufacturing

| -89.04% | O: 4.95% H: 0.0% C: -9.91%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

Health Technology

| 25.85% | O: 0.03% H: 2.26% C: 2.1%

AC Immune Reports First Quarter 2023 Financial Results and Provides a Corporate Update
Published: 2023-04-28 (Crawled : 12:20) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M

Health Technology

| 89.33% | O: 1.96% H: 1.59% C: -0.54%
ACIU | $2.33 -2.1% -2.15% 320K

Health Technology

| 26.6% | O: 0.0% H: 3.46% C: 3.19%
update financial results

Blue Water Announces Acquisition of ENTADFI®, an FDA-Approved Benign Prostatic Hyperplasia Asset
Published: 2023-04-20 (Crawled : 12:20) - biospace.com/
BWV | $0.1802 5.44% 530K

| -83.37% | O: 1.51% H: 2.73% C: -2.73%
LLY | News | $732.2 -1.81% 0.18% 2.1M

Health Technology

| 99.49% | O: 0.25% H: 1.26% C: 0.92%
VERU | $1.325 3.92% 3.77% 1.5M

Health Technology

| 23.3% | O: 2.91% H: 16.04% C: 13.21%
entadfi water acquisition blue

ProQR Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D Event
Published: 2023-03-29 (Crawled : 12:20) - globenewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M

Health Technology

| 118.88% | O: 0.4% H: 0.23% C: -0.92%
PRQR | News | $2.0 -0.99% -1.0% 36K

Health Technology

| -43.58% | O: -10.34% H: 1.56% C: -21.5%
axiomer pipeline technology platform

AC Immune at AD/PD™ 2023 to Present New Clinical and Preclinical Data from its Precision Medicine Pipeline
Published: 2023-03-20 (Crawled : 12:20) - globenewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M

Health Technology

| 124.51% | O: 0.0% H: 1.45% C: 1.34%
ACIU | $2.33 -2.1% -2.15% 320K

Health Technology

| 7.21% | O: 0.9% H: 3.13% C: -3.57%
pipeline preclinical

AC Immune Reports Full Year 2022 Financial Results and Provides Corporate Update
Published: 2023-03-16 (Crawled : 12:20) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -3.04% | O: -0.58% H: 0.6% C: 0.38%
LLY | News | $732.2 -1.81% 0.18% 2.1M

Health Technology

| 124.31% | O: -0.56% H: 1.24% C: 0.58%
ACIU | $2.33 -2.1% -2.15% 320K

Health Technology

| 3.48% | O: 0.0% H: 6.09% C: 0.43%
year update financial results

AC Immune’s ACI-24.060 Anti-Amyloid Beta Vaccine for Alzheimer’s Shows Positive Initial Interim Safety and Immunogenicity in Phase 1b/2 ABATE Trial
Published: 2023-01-26 (Crawled : 12:20) - globenewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M

Health Technology

| 111.32% | O: 0.36% H: 0.34% C: -0.85%
ACIU | $2.33 -2.1% -2.15% 320K

Health Technology

| 1.71% | O: 10.68% H: 0.0% C: -7.34%
aci-24 vaccine trial alzheimer’s positive aci-24.060 anti-amyloid beta phase 2b

AC Immune Partner Life Molecular Imaging Initiates Phase 3 Study of Tau PET Diagnostic PI-2620 for Alzheimer’s Disease
Published: 2023-01-18 (Crawled : 12:20) - globenewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M

Health Technology

| 106.59% | O: -0.4% H: 0.75% C: -1.21%
ACIU | $2.33 -2.1% -2.15% 320K

Health Technology

| 1.28% | O: 4.26% H: 0.0% C: -4.9%
pi-2620 disease diagnostic life tau imaging alzheimer’s molecular study

AMR Action Fund Announces Investment in BioVersys AG
Published: 2023-01-05 (Crawled : 12:20) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -16.92% | O: -0.62% H: 0.54% C: -0.12%
LLY | News | $732.2 -1.81% 0.18% 2.1M

Health Technology

| 103.54% | O: -0.59% H: 0.15% C: -0.56%

CANCER RESEARCH INSTITUTE VIRTUAL IMMUNOTHERAPY PATIENT SUMMIT IS NOW AVAILABLE FREE, ON-DEMAND
Published: 2022-12-08 (Crawled : 12:20) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480

Health Technology

| -0.19% | O: 0.5% H: 0.16% C: 0.16%
LLY | News | $732.2 -1.81% 0.18% 2.1M

Health Technology

| 98.69% | O: 0.35% H: 0.0% C: -0.39%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -0.83% | O: -1.32% H: 0.0% C: 0.0%
REGN | News | $906.55 -0.09% -0.08% 370K

Health Technology

| 18.72% | O: -0.81% H: 2.76% C: 0.97%
research immunotherapy cancer

Akouos Reports Third Quarter 2022 Financial Results and Provides Business Highlights
Published: 2022-11-14 (Crawled : 12:20) - globenewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M

Health Technology

| 109.78% | O: 1.92% H: 0.48% C: -0.84%
AKUS | $13.29 1.07% 3.46%

Health Technology

| -1.64% | O: -0.82% H: 0.0% C: 0.0%
financial results

AC Immune Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
Published: 2022-10-28 (Crawled : 12:20) - globenewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M

Health Technology

| 107.41% | O: 1.12% H: 0.47% C: -0.12%
ACIU | $2.33 -2.1% -2.15% 320K

Health Technology

| -23.23% | O: 0.97% H: 0.0% C: -7.51%
financial update results

HUTCHMED Reports 2022 Interim Results and Provides Business Updates
Published: 2022-08-01 (Crawled : 12:20) - chi-med.com
LLY | News | $732.2 -1.81% 0.18% 2.1M

Health Technology

| 124.17% | O: -0.66% H: 0.89% C: -1.03%
results